Back to Epoch Investment Partners, Inc. Epoch Investment Partners, Inc.

REGN

10 quarters

Position history for Epoch Investment Partners, Inc.Epoch Investment Partners, Inc.'s holdings in Regeneron Pharmaceuticals, Inc.

Yes. Epoch Investment Partners holds 186,850 shares of REGN (Regeneron Pharmaceuticals), worth $116.5M, as of its Q2 2026 13F filing. It reduced the position by 51,875 shares (-21.7%) from Q1 2026. Epoch Investment Partners has held REGN since Q1 2024, across 10 quarterly 13F filings. REGN is 0.7% of Epoch Investment Partners' reported 13F portfolio.

Current Value

$116.5M

Current Shares

186,850

Total Value Change

+$16.8M

Total Shares Change

+83,299

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
186,850
-21.7%
$116.5M0.7%$622.81
0
2026-Q1
Decreased
238,725
-15.2%
$184.4M1.1%$770.59
0
2025-Q4
Increased
281,335
+8.6%
$217.2M1.2%$768.90
52
2025-Q3
Increased
259,153
+27.6%
$145.7M0.8%$559.40
53
2025-Q2
Decreased
203,057
-2.1%
$106.6M0.6%$521.53
0
2025-Q1
Increased
207,456
+5.2%
$131.6M0.7%$629.11
45
2024-Q4
Increased
197,266
+25.1%
$140.5M0.7%$705.67
52
2024-Q3
Decreased
157,740
-3.4%
$165.8M0.7%$1,041.41
0
2024-Q2
Increased
163,296
+57.7%
$171.6M0.8%$1,041.20
61
2024-Q1
New
103,551
-
$99.7M0.4%$953.49
50

Other major holders of REGN: FMR LLC, Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used